Less Ads, More Data, More Tools Register for FREE

Acquisition Update

13 Jul 2009 11:33

RNS Number : 5566V
The MedicX Fund Limited
13 July 2009
 



For immediate release 13 July 2009

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Acquisition update

MedicX Fund, (LSE: MXF) , the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom, today announces an update on acquisition progress.

In its interim announcement on 28 May 2009, the Fund announced that it had agreed to enter into two forward funding arrangements with a combined investment of £15.2 million. As previously reported, the forward funding agreement for the Abergele property has been completed and development of this property with a total acquisition cost of £3.3 million is due to complete in December 2009. Having agreed terms for the acquisition of the second of these properties, at St Annes, for a total acquisition cost of £11.9 million the vendor has subsequently decided to retain the property.

The Fund is in advanced negotiations regarding the purchase of a number of properties and will advise on completion of any acquisition in due course.

The total property portfolio comprises 46 properties throughout the UK of which two are under construction.

End

For further information please contact:

MedicX Fund +44 (0) 1481 723 450

David Staples, Chairman 

MedicX Group +44 (0) 808 2025461

Keith Maddin, Chairman

Mike Adams, Managing Director

Buchanan Communications +44 (0) 20 7466 5000

Charles Ryland / Mary-Jane Johnson / Miranda Higham

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFGGMNGFMGLZM

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS